Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy

NCT03239535 is registered in ClinicalTrials.gov with Federal Research Clinical Center of Federal Medical & Biological Agency, Russia as lead sponsor.

NCT NCT03239535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy
Lead sponsor
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 1, 2013
Completion date
November 1, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia